A detailed history of Cwm, LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 65 shares of ATXS stock, worth $620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Previous 56 16.07%
Holding current value
$620
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$8.97 - $12.65 $80 - $113
9 Added 16.07%
65 $1,000
Q2 2024

Jul 09, 2024

BUY
$8.83 - $13.51 $70 - $108
8 Added 16.67%
56 $1,000
Q4 2023

Feb 01, 2024

BUY
$4.42 - $8.06 $212 - $386
48 New
48 $0

Others Institutions Holding ATXS

About Astria Therapeutics, Inc.


  • Ticker ATXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,178,000
  • Market Cap $145M
  • Description
  • Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...
More about ATXS
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.